135 related articles for article (PubMed ID: 36678513)
1. Preclinical Studies of Chiauranib Show It Inhibits Transformed Follicular Lymphoma through the VEGFR2/ERK/STAT3 Signaling Pathway.
Tang Y; Zhong M; Pan G; Tan J; Xie C; Jiang Y; Yao J; Shan W; Lin J; Huang J; Liu Y; Li Z; Xu B; Zha J
Pharmaceuticals (Basel); 2022 Dec; 16(1):. PubMed ID: 36678513
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase.
Gao T; Huang J; Yin H; Huang J; Xie J; Zhou T; Fan W; Yang X; Gao G; Li Z
Cell Death Dis; 2023 May; 14(5):316. PubMed ID: 37160920
[TBL] [Abstract][Full Text] [Related]
3. Phase I dose-escalation study of chiauranib, a novel angiogenic, mitotic, and chronic inflammation inhibitor, in patients with advanced solid tumors.
Sun Y; Yang L; Hao X; Liu Y; Zhang J; Ning Z; Shi Y
J Hematol Oncol; 2019 Jan; 12(1):9. PubMed ID: 30642372
[TBL] [Abstract][Full Text] [Related]
4. Chiauranib selectively inhibits colorectal cancer with
Yin H; Xie J; Jiang P; Jiang X; Duan D; Qi J; Luo Z; Ma C; Hong H
Am J Cancer Res; 2020; 10(11):3666-3685. PubMed ID: 33294260
[TBL] [Abstract][Full Text] [Related]
5. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
6. CS2164 suppresses acute myeloid leukemia cell growth via inhibiting VEGFR2 signaling in preclinical models.
Deng M; Zhao H; Chen Q; Zhao J; Shi Y; Yu L; Fang Z; Xu B
Eur J Pharmacol; 2019 Jun; 853():193-200. PubMed ID: 30928630
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma.
Zhong M; Tan J; Pan G; Jiang Y; Zhou H; Lai Q; Chen Q; Fan L; Deng M; Xu B; Zha J
Front Oncol; 2021; 11():780118. PubMed ID: 34926293
[TBL] [Abstract][Full Text] [Related]
8. Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer.
Xie C; Zhou X; Liang C; Li X; Ge M; Chen Y; Yin J; Zhu J; Zhong C
J Exp Clin Cancer Res; 2021 Aug; 40(1):266. PubMed ID: 34429133
[TBL] [Abstract][Full Text] [Related]
9. Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia.
Deng M; Zha J; Jiang Z; Jia X; Shi Y; Li P; Chen XL; Fang Z; Du Z; Xu B
J Transl Med; 2018 Feb; 16(1):47. PubMed ID: 29490645
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases.
Liu W; Lu Y; Chai X; Liu X; Zhu T; Wu X; Fang Y; Liu X; Zhang X
J Exp Clin Cancer Res; 2016 Nov; 35(1):183. PubMed ID: 27887633
[TBL] [Abstract][Full Text] [Related]
11. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
[TBL] [Abstract][Full Text] [Related]
12. BET bromodomain inhibitors PFI-1 and CPI-203 suppress the development of follicular lymphoma via regulating Wnt/β-catenin signaling.
Bai M; Huang Y; Suo X; Wang L; Han W; Zhang W
Heliyon; 2024 Mar; 10(5):e27149. PubMed ID: 38463851
[TBL] [Abstract][Full Text] [Related]
13. Effects of combined inhibition of STAT3 and VEGFR2 pathways on the radiosensitivity of non-small-cell lung cancer cells.
Hu C; Zhuang W; Qiao Y; Liu B; Liu L; Hui K; Jiang X
Onco Targets Ther; 2019; 12():933-944. PubMed ID: 30774379
[TBL] [Abstract][Full Text] [Related]
14. CS2164 exerts an antitumor effect against human Non-Hodgkin's lymphomas in vitro and in vivo.
Deng M; Shi Y; Chen K; Zhao H; Wang Y; Xie S; Zhao J; Luo Y; Fang Z; Fan Y; Xu B
Exp Cell Res; 2018 Aug; 369(2):356-362. PubMed ID: 29864401
[TBL] [Abstract][Full Text] [Related]
15. Natural product pectolinarigenin inhibits proliferation, induces apoptosis, and causes G2/M phase arrest of HCC via PI3K/AKT/mTOR/ERK signaling pathway.
Wu T; Dong X; Yu D; Shen Z; Yu J; Yan S
Onco Targets Ther; 2018; 11():8633-8642. PubMed ID: 30584322
[TBL] [Abstract][Full Text] [Related]
16. Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma.
Liu K; Ren T; Huang Y; Sun K; Bao X; Wang S; Zheng B; Guo W
Cell Death Dis; 2017 Aug; 8(8):e3015. PubMed ID: 28837148
[TBL] [Abstract][Full Text] [Related]
17. B7-H6 Promotes Cell Proliferation, Migration and Invasion of Non-Hodgkin Lymphoma via Ras/MEK/ERK Pathway Based on Quantitative Phosphoproteomics Data.
Yang S; Yuan L; Wang Y; Zhu M; Wang J; Ke X
Onco Targets Ther; 2020; 13():5795-5805. PubMed ID: 32606790
[TBL] [Abstract][Full Text] [Related]
18. Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes.
Lang SA; Schachtschneider P; Moser C; Mori A; Hackl C; Gaumann A; Batt D; Schlitt HJ; Geissler EK; Stoeltzing O
Mol Cancer Ther; 2008 Nov; 7(11):3509-18. PubMed ID: 19001434
[TBL] [Abstract][Full Text] [Related]
19. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.
Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C
Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882
[TBL] [Abstract][Full Text] [Related]
20. Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway.
Lin W; Zheng L; Zhuang Q; Zhao J; Cao Z; Zeng J; Lin S; Xu W; Peng J
BMC Complement Altern Med; 2013 Jun; 13():144. PubMed ID: 23800091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
